Cargando…

Revealing the favorable dissociation pathway of type II kinase inhibitors via enhanced sampling simulations and two-end-state calculations

How does a type II inhibitor bind to/unbind from a kinase target is still a confusing question because the small molecule occupies both the ATP pocket and the allosteric pocket of the kinase binding site. Here, by using enhanced sampling simulations (umbrella sampling, US) and two-end-state free ene...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Huiyong, Tian, Sheng, Zhou, Shunye, Li, Youyong, Li, Dan, Xu, Lei, Shen, Mingyun, Pan, Peichen, Hou, Tingjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326958/
https://www.ncbi.nlm.nih.gov/pubmed/25678308
http://dx.doi.org/10.1038/srep08457
_version_ 1782356981365866496
author Sun, Huiyong
Tian, Sheng
Zhou, Shunye
Li, Youyong
Li, Dan
Xu, Lei
Shen, Mingyun
Pan, Peichen
Hou, Tingjun
author_facet Sun, Huiyong
Tian, Sheng
Zhou, Shunye
Li, Youyong
Li, Dan
Xu, Lei
Shen, Mingyun
Pan, Peichen
Hou, Tingjun
author_sort Sun, Huiyong
collection PubMed
description How does a type II inhibitor bind to/unbind from a kinase target is still a confusing question because the small molecule occupies both the ATP pocket and the allosteric pocket of the kinase binding site. Here, by using enhanced sampling simulations (umbrella sampling, US) and two-end-state free energy calculations (MM/GSBA), we systemically studied the dissociation processes of two distinct small molecules escaping from the binding pocket of p38 MAP kinase through the allosteric channel and the ATP channel. The results show that the unbinding pathways along the allosteric channel have much lower PMF depths than those along the ATP channel, suggesting that the allosteric channel is more favorable for the dissociations of the two inhibitors and thereby supporting the general understanding that the largest channel of a target is usually the entry/exit pathway for the binding/dissociation of small molecules. Interestingly, the MM/GBSA approach yielded similar PMF profiles compared with those based on US, a much time consuming approach, indicating that for a general study, such as detecting the important transition state of a ligand binding/unbinding process, MM/GBSA may be a feasible choice.
format Online
Article
Text
id pubmed-4326958
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-43269582015-02-23 Revealing the favorable dissociation pathway of type II kinase inhibitors via enhanced sampling simulations and two-end-state calculations Sun, Huiyong Tian, Sheng Zhou, Shunye Li, Youyong Li, Dan Xu, Lei Shen, Mingyun Pan, Peichen Hou, Tingjun Sci Rep Article How does a type II inhibitor bind to/unbind from a kinase target is still a confusing question because the small molecule occupies both the ATP pocket and the allosteric pocket of the kinase binding site. Here, by using enhanced sampling simulations (umbrella sampling, US) and two-end-state free energy calculations (MM/GSBA), we systemically studied the dissociation processes of two distinct small molecules escaping from the binding pocket of p38 MAP kinase through the allosteric channel and the ATP channel. The results show that the unbinding pathways along the allosteric channel have much lower PMF depths than those along the ATP channel, suggesting that the allosteric channel is more favorable for the dissociations of the two inhibitors and thereby supporting the general understanding that the largest channel of a target is usually the entry/exit pathway for the binding/dissociation of small molecules. Interestingly, the MM/GBSA approach yielded similar PMF profiles compared with those based on US, a much time consuming approach, indicating that for a general study, such as detecting the important transition state of a ligand binding/unbinding process, MM/GBSA may be a feasible choice. Nature Publishing Group 2015-02-13 /pmc/articles/PMC4326958/ /pubmed/25678308 http://dx.doi.org/10.1038/srep08457 Text en Copyright © 2015, Macmillan Publishers Limited. All rights reserved http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder in order to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Sun, Huiyong
Tian, Sheng
Zhou, Shunye
Li, Youyong
Li, Dan
Xu, Lei
Shen, Mingyun
Pan, Peichen
Hou, Tingjun
Revealing the favorable dissociation pathway of type II kinase inhibitors via enhanced sampling simulations and two-end-state calculations
title Revealing the favorable dissociation pathway of type II kinase inhibitors via enhanced sampling simulations and two-end-state calculations
title_full Revealing the favorable dissociation pathway of type II kinase inhibitors via enhanced sampling simulations and two-end-state calculations
title_fullStr Revealing the favorable dissociation pathway of type II kinase inhibitors via enhanced sampling simulations and two-end-state calculations
title_full_unstemmed Revealing the favorable dissociation pathway of type II kinase inhibitors via enhanced sampling simulations and two-end-state calculations
title_short Revealing the favorable dissociation pathway of type II kinase inhibitors via enhanced sampling simulations and two-end-state calculations
title_sort revealing the favorable dissociation pathway of type ii kinase inhibitors via enhanced sampling simulations and two-end-state calculations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326958/
https://www.ncbi.nlm.nih.gov/pubmed/25678308
http://dx.doi.org/10.1038/srep08457
work_keys_str_mv AT sunhuiyong revealingthefavorabledissociationpathwayoftypeiikinaseinhibitorsviaenhancedsamplingsimulationsandtwoendstatecalculations
AT tiansheng revealingthefavorabledissociationpathwayoftypeiikinaseinhibitorsviaenhancedsamplingsimulationsandtwoendstatecalculations
AT zhoushunye revealingthefavorabledissociationpathwayoftypeiikinaseinhibitorsviaenhancedsamplingsimulationsandtwoendstatecalculations
AT liyouyong revealingthefavorabledissociationpathwayoftypeiikinaseinhibitorsviaenhancedsamplingsimulationsandtwoendstatecalculations
AT lidan revealingthefavorabledissociationpathwayoftypeiikinaseinhibitorsviaenhancedsamplingsimulationsandtwoendstatecalculations
AT xulei revealingthefavorabledissociationpathwayoftypeiikinaseinhibitorsviaenhancedsamplingsimulationsandtwoendstatecalculations
AT shenmingyun revealingthefavorabledissociationpathwayoftypeiikinaseinhibitorsviaenhancedsamplingsimulationsandtwoendstatecalculations
AT panpeichen revealingthefavorabledissociationpathwayoftypeiikinaseinhibitorsviaenhancedsamplingsimulationsandtwoendstatecalculations
AT houtingjun revealingthefavorabledissociationpathwayoftypeiikinaseinhibitorsviaenhancedsamplingsimulationsandtwoendstatecalculations